FDAnews
www.fdanews.com/articles/81706-alinea-pharma-gets-45m

ALINEA PHARMA GETS $45M

October 17, 2005

MPM Capital Ventures said Tuesday it has invested $45 million in Alinea Pharmaceuticals, a biotech firm working on methods for treating complications associated with diabetes. Todd Foley, a partner at MPM who led the search for a suitable investment, said Alinea is working on a treatment for diabetic neuropathy-a form of nerve damage that afflicts a large number of diabetic patients. The clinical-stage startup is also working on a program that would improve how diabetics manage their blood sugar.

Red Herring (http://www.redherring.com/Article.aspx?a=13954&hed=Alinea%2BPharma%2BGets%2B%2445M)